Onderzoeker
Sam Lievens
- Disciplines:Small molecules, Andere biotechnologie, bio-en biosysteem ingenieurswetenschappen niet elders geclassificeerd, Medische biotechnologie niet elders geclassificeerd, Cel-, weefsel- en orgaan engineering, Cellulaire therapie, Ontdekking en evaluatie van geneesmiddelen niet elders geclassificeerd, Dierlijke cel- en moleculaire biologie, Klinische trials, Compound screening, In vitro testen, Niet-klinische studies
Affiliaties
- Vakgroep Biochemie (Departement)
Lid
Vanaf1 feb 2002 → 31 dec 2015 - Vakgroep Plantenbiotechnologie en Bio-informatica (Departement)
Lid
Vanaf1 okt 1995 → 28 feb 2001
Projecten
1 - 1 of 1
- Het bouwen van een MASPIT cel microarray-based klein molecuul doelwit profilering dienstVanaf1 mei 2013 → 31 jan 2015Financiering: IOF - Industrieel Onderzoeksfonds
Publicaties
1 - 10 van 50
- Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease(2018)
Auteurs: Michael Dumbacher, Tom Van Dooren, Katrien Princen, Koen De Witte, Mélissa Farinelli, Samuel Lievens, Jan Tavernier, Wim Dehaen, Stefaan Wera, Joris Winderickx, et al.
- Glucocorticoid receptor-mediated transactivation is hampered by Striatin-3, a novel interaction partner of the receptor(2017)
Auteurs: Nadia Bougarne, Jolien Vandewalle, Lien Dejager, Sofie Vandevyver, Sofie Desmet, Lode De Cauwer, Samuel Lievens, Claude Libert, Jan Tavernier
- MAPPI-DAT : data management and analysis for protein-protein interaction data from the high-throughput MAPPIT cell microarray platform(2017)
Auteurs: Surya Gupta, Veronic De Puysseleyr, José Van Der Heyden, Davy Maddelein, Irma Lemmens, Samuel Lievens, Jan Tavernier, Lennart Martens
Pagina's: 1424 - 1425 - RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes(2017)
Auteurs: Delphine Masschaele, Leentje De Ceuninck, Joris Wauman, Dieter Defever, Frank Stenner, Samuel Lievens, Frank Peelman, Jan Tavernier
- Ubiquitin D regulates IRE1 α/c-Jun N-terminal kinase (JNK) protein-dependent apoptosis in pancreatic beta cells(2016)
Auteurs: Flora Brozzi, Fabio Arturo Grieco, Matilda Juusola, Alexander Balhuizen, Samuel Lievens, Conny Gysemans, Marco Bugliani, Chantal Mathieu, Piero Marchetti, Jan Tavernier, et al.
Pagina's: 12040 - 12056 - Chemical dimerizers in three-hybrid systems for small molecule-target protein profiling(2016)
Auteurs: Dries De Clercq, Jan Tavernier, Samuel Lievens
Pagina's: 2075 - 2090 - Modulation of protein-protein interactions for the development of novel therapeutics(2016)
Auteurs: Samuel Lievens, Claude Libert, Jan Tavernier
Pagina's: 707 - 718 - Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARU+03B1(2016)
Auteurs: Dariusz Ratman, Nadia Bougarne, Michal Pawlak, Sandrine Caron, Nathalie Hennuyer, Réjane Paumelle, Lode De Cauwer, Mark H Rider, Claude Libert, Samuel Lievens, et al.
Pagina's: 10539 - 10553 - The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases(2016)
Auteurs: Lien Dejager, Samuel Lievens, Jan Tavernier, Claude Libert
Pagina's: 495 - 522 - OTUB1 triggers lung cancer development by inhibiting RAS monoubiquitination(2016)
Auteurs: Maria Francesca Baietti, Michal Simicek, Layka Abbasi Asbagh, Enrico Radaelli, Samuel Lievens, Jonathan Crowther, Mikhail Steklov, Vasily N Aushev, David Martínez García, Jan Tavernier, et al.
Pagina's: 288 - 303
Patenten
1 - 3 van 3